Attempts to destigmatize depression often rely on comparing mental illnesses to physical ailments. Diabetes, cancer, and asthma are just some of the conditions employed as analogies, all with the goal of increasing understanding of depression and seeking to legitimize the experience of mental illness. After all, virtually everyone has suffered from a physical illness at some point and can recognize those ailments as real and involuntary. It is a way of establishing a common language and saying, “This is real. This counts.”
But while depression is indeed every bit as legitimate as physical conditions, it also differs sharply from the vast majority of medical conditions in that there are currently no clear biological markers of the illness. There is no blood test, no cell analysis, no ultrasound or MRI. This lack of concrete material evidence of depression means that you are highly reliant on the expertise of your psychiatrist for diagnosis, making it more imperative than ever to seek out the highest quality care possible. It also means that once you get that diagnosis, treatment itself is largely an open frontier; there is no surefire way to predict what kind of care you will respond to, no plasma values that tell you Treatment A will work better than Treatment B. As a result, pharmacological treatment is largely a process of trial and error, one that can be time-consuming, frustrating, and expensive. It is estimated that roughly 50% of people with depression do not respond to first-line antidepressants and 10-30% “do not improve or show a partial response coupled with functional impairment, poor quality of life, suicide ideation and attempts, self-injurous behavior, and a high relapse rate.”



